| Serial Number | 90226522 |
| Word Mark | TIME IS LIFE |
| Filing Date | Wednesday, September 30, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, July 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Financial sponsorship of clinical and translational trials in the field of cancer treatment |
| Goods and Services | Promoting collaboration and the exchange of information and resources within the scientific, research, medical, clinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatment |
| Goods and Services | Providing medical information featuring profiles of cancer patients' tumours and the associated clinical and molecular data, and medical information pertaining to cancer drugs, biomarkers, biological and tissue samples, and results of clinical studies, via an on-line searchable database; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; providing medical information concerning quality of life in the fields of the treatment of cancer, the likelihood of success of the treatment of cancer, the physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; providing medical information in the nature of medical data pertaining to cancer and its treatment; providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment; providing medical information pertaining to cancer and its treatment |
| Goods and Services | Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; medical and scientific research in the field of cancer treatment; providing research information in the nature of medical research data pertaining to cancer and its treatment; conducting translational trials for others in the field of cancer treatment, consisting of a combination of clinical research and scientific research; conducting trials in the field of cancer treatment for others; providing clinical trial information in the nature of medical and scientific research data pertaining to cancer; providing medical research information pertaining to cancer and its treatment |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Exactis Innovation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Montréal, Québec H3T1Y6 CA |
| Event Date | Event Description |
| Saturday, October 3, 2020 | NEW APPLICATION ENTERED |
| Saturday, November 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 24, 2021 | ASSIGNED TO EXAMINER |
| Thursday, February 25, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, March 11, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 25, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, February 25, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 11, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 19, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, April 19, 2021 | LETTER OF SUSPENSION E-MAILED |
| Monday, April 19, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, October 27, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Sunday, November 28, 2021 | SUSPENSION INQUIRY WRITTEN |
| Sunday, November 28, 2021 | INQUIRY TO SUSPENSION E-MAILED |
| Sunday, November 28, 2021 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, May 25, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Saturday, May 28, 2022 | ASSIGNED TO LIE |
| Thursday, June 2, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 2, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 15, 2022 | SUSPENSION LETTER WRITTEN |
| Friday, July 15, 2022 | LETTER OF SUSPENSION E-MAILED |
| Friday, July 15, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, January 27, 2023 | SUSPENSION INQUIRY WRITTEN |
| Friday, January 27, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Friday, January 27, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, April 12, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, April 20, 2023 | ASSIGNED TO LIE |
| Friday, April 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 15, 2023 | SUSPENSION LETTER WRITTEN |
| Saturday, July 15, 2023 | LETTER OF SUSPENSION E-MAILED |
| Saturday, July 15, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, February 5, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Saturday, July 13, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Saturday, July 13, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Sunday, March 10, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Sunday, March 10, 2024 | SUSPENSION INQUIRY WRITTEN |
| Sunday, March 10, 2024 | INQUIRY TO SUSPENSION E-MAILED |